Board Member Profile

Director

(Date of birth: Oct. 13, 1960)

Profile

Apr. 1985	Joined Fuji Photo Film Co., Ltd. (currently FUJIFILM Corp.(FUJIFILM))
Oct. 1996	Manager, Ashigara Research Laboratories, FUJIFILM
Apr. 2004	Senior manager, Research and Development Management HQ, Digital & Photo Imaging Material Research Laboratories, FUJIFILM
Jun. 2007	Deputy General Manager, life science Research Laboratories, Research and Development Management HQ / Senior Manager, Business Development Office Life Science Business Division, FUJIFILM
Jul. 2008	Toyama Chemical Co., Ltd. (currently FUJIFILM Toyama Chemical Co., Ltd.)　on loan
Jun. 2009	General Manager, Drug Discovery Research Laboratories, Research and Development Management HQ, FUJIFILM
Sep. 2013	General Manager, Regenerative Medicine Business Development Office/Deputy General Manager, Pharmaceutical Products. Div., FUJIFILM
Apr. 2015	Manager, Regenerative Medicine Business Development Office, FUJIFILM /　Forum for Innovative Regenerative Medicine,　on loan
Dec. 2017	Manager, Healthcare Business Development Office, FUJIFILM
Mar. 2018	Director, Perseus Proteomics Inc. (the Company)
Jun. 2018	President & CEO, the Company (to present)
Jan. 2019	Executive Officer, the Company (to present)

(Date of birth: Sep. 20, 1955)

Profile

Apr. 1978	Joined Kokusai Denshin Denwa Co. Ltd. (currently KDDI CORPORATION）
Jul. 1996	Vice President, KDD Europe (currently KDDI Europe)
Feb. 2002	President, Telehouse Europe
Apr. 2005	Network Solution KANSAI Regional Office, KDDI CORPORATION (KDDI)
Apr. 2008	Regional Executive Officer, Asia Pacific/President, KDDI Singapore
Jan. 2010	Vice Chairman, DMX Technologies Group LTD
Jan. 2013	Executive Director, Global ICT Business Division, Global Business Sector, KDDI
Jun. 2016	Statutory Auditor, KDDI Evolva, Inc.
Sep. 2018	Outside Director, ACSL Ltd.
Jun. 2019	Statutory Auditor, the Company
Jun. 2020	Director, Executive Officer & Head of Administrative Dept.,the Company (to present)

(Date of birth: Jan. 28, 1959)

Profile

Apr. 1988	Assistant, School of Medicine, Shinshu University
Oct. 1992	Research Associate, Dartmouth Medical School
Oct. 1997	Researcher, Institute of Biotechnology and Industrial Technology, Agency of Industrial Science and Technology, Ministry of Trade and Industry (currently Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, National Research and Development Agency)
Apr. 2002	Joined HuBit genomix Co., Ltd. (HuBit)
Apr. 2003	Manager, Research and Development Dept., HuBit
May. 2005	Joined the Company
Feb. 2009	Head of Research and Development Dept., the Company
Jan. 2019	Executive Officer & Head of Research and Development Dept., the Company
Jun. 2019	Director, the Company (to present)
Jun. 2022	Executive Officer & CTO, the Company (to present)

(Date of birth: Jan. 20, 1967)

Profile

Jul. 1994	PhD, Researcher, Imperial Cancer Research Fund Laboratories
Sep. 1998	Assistant Professor, Medical Institute of Bioregulation, Kyushu University
Jun. 2001	Joined Nomura Securities, Co., Ltd. (Nomura Securities) Nomura Research and Advisory Co., Ltd. (NRA) on loan
Jun. 2011	Executive Director, Investment Dept. NRA
Apr. 2013	Section Chief, Regional Financial Institutional and Public Sector Clients Consulting Dept., Nomura Securities
Aug. 2015	Director, Corporate Business Group, Mizuho Securities, Co., Ltd.
Sep. 2017	President & CEO, Tech & FinStrategy Inc. (to present)
Oct. 2017	Outside Director, Cellspect Co., Ltd. (to present)
Jun. 2018	Director, the Company (to present) Outside Director, Delta-Fly Pharma, Inc. (to present)
Aug. 2019	Outside Director, Veritas In Silico Inc. (to present)
Aug. 2021	Outside Director, EGAIA Co., Ltd. (to present)
Dec. 2021	Outside Director, RMiC : Regenerative Medicine iPS Gateway Center Co., Ltd. (currently Repli-tech Co., Ltd.) (to present)
Feb. 2022	Director, TransMed, Inc. (to present)

(Date of birth: Apr. 30, 1953)

Profile

Apr. 1976	Joined Kyowa Hakko Kogyo Co., Ltd.
Feb. 2003	President, BioWa, Inc.
Jun. 2006	Executive Officer, Kyowa Hakko Kogyo Co., Ltd.
Oct. 2008	Operating Director & Head of Development Dept., Kyowa Hakko Kirin Co., Ltd. (currently Kyowa Kirin Co., Ltd.）
Apr. 2009	Managing Executive Officer & Head of Development Dept., Kyowa Kirin Co., Ltd. (Kyowa Kirin)
Jun. 2009	Director & Senior Managing Executive Officer, Kyowa Kirin
Mar. 2010	Director & Executive Operating Officer, Kyowa Kirin
Mar. 2012	Executive Director, President & CEO, Kyowa Kirin
Mar. 2018	Executive Director, Chairman & CEO, Kyowa Kirin
Mar. 2019	Director & Chairman, Kyowa Kirin
May. 2020	Director, Leave a Nest Co., Ltd. (to present)
Jun. 2020	Outside Director, Shimadzu Corp. (to present)
Mar. 2021	Director, the Company (to present)
Jun. 2021	Outside Director, Aculys Pharma, Inc. (to present)

(Date of birth: Dec. 7, 1956）

Profile

Apr. 1981	Joined Kokusai Denshin Denwa Co., Ltd (currently KDDI CORPORATION)
Sep. 2000	Managing Director, KDDI Australia Pty Ltd
Apr. 2010	Internal Control Manager, Risk Management HQ, KDDI CORPORATION
Jul. 2011	Full-time Audit & Supervisory Board Member, Evolva Business Support, Inc. (currently　KDDI Evolva, Inc.)
Jul. 2013	Full-time Audit & Supervisory Board Member, KDDI Evolva Call Advance, Inc. (currently　KDDI Evolva, Inc.)
Apr. 2017	Audit & Supervisory Board Member, ARISE analytics Inc.
Jun. 2017	Audit & Supervisory Board Member, Japan Internet Exchange Co., Ltd.
Aug. 2017	Audit & Supervisory Board Member, SORACOM, INC.
Jul. 2019	Full-time Audit & Supervisory Board Member, CREEMA LTD.
Oct. 2019	Outside Audit & Supervisory Board Member, Japaniace Co., Ltd.　(to present)
May 2020	Full-time Outside Audit & Supervisory Board Member, GEOCODE CO.,Ltd.
Jun. 2022	Director, Audit & Supervisory Committee Member, the Company (to present)

(Date of birth: Sep. 26, 1946)

Profile

Apr. 1972	Joined Daiichi Pharmaceutical Co., Ltd (currently Daiichi Sankyo Co., Ltd.)
Apr. 1989	Senior Researcher, Molecular Biology Laboratory, Daiichi Sankyo Co., Ltd. (Daiichi)
Oct. 1996	General Manager, Drug Discovery Research Laboratory, Daiichi
Oct. 1999	Corporate Officer & General Manager, Drug Discovery Research Laboratory, Daiichi
Apr. 2007	Standing Statutory Auditor, Asubio Pharma Co., Ltd. (currently Daiichi Sankyo Co., Ltd.)
Jul. 2008	Senior Coodinator, Center for Research Promotion, Comprehensive Research Promotion Organization, Keio University
Apr. 2016	Guest Professor, Clinical & Translational Research Center, School of Medicine, Keio University (to present)
Sep. 2017	Science and Technical Advisor, Japan Agency for Medical Research and Development
Jun. 2019	Statutory Auditor, the Company
Jun. 2020	Director, Audit & Supervisory Committee Member, the Company (to present)

(Date of birth: Dec. 14, 1969)

Profile

Mar. 1996	Joined Showa Ota & Co. (currently Ernst & Young ShinNihon LLC)
Oct. 1998	Joined Asahi & Co. (currently KPMG AZSA LLC）
Apr. 2000	Registered as Certified Public Accountant
Apr. 2002	Registered as Certified Public Tax Accountant
Jan. 2006	Joined Ichiyoshi Securities Co., Ltd.
Feb. 2010	Joined CMIC Co., Ltd. (currently CMIC HOLDINGS Co., Ltd.)
Oct. 2016	Representative, Ohno Certified Public Accountant’s Office (to present)
Jun. 2021	Director, Audit & Supervisory Committee Member, the Company (to present)
Sep. 2021	Representative Partner, Mita-Kaikeisha Tax Co. (to present)